An extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Pulmonary Hypertension
Age: Between 0 - 99 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required